Succinate recovers mitochondrial oxygen consumption in septic rat skeletal muscle

Critical Care Medicine

Volumn 35, Issue 9, 2007, Pages 2150-2155

  Protti, Alessandro ^a,b   Carré, Jane ^a   Frost, Matthew T ^a   Taylor, Valerie ^a   Stidwill, Raymond ^a   Rudiger, Alain ^a   Singer, Mervyn ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Complex I; Mitochondria; Multiple organ failure; Oxygen consumption; Sepsis; Succinate

Indexed keywords

GLUTAMIC ACID; MALIC ACID; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONSCIOUSNESS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EX VIVO STUDY; FLUID RESUSCITATION; HEMODYNAMICS; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE TISSUE; NONHUMAN; OXYGEN CONSUMPTION; PERITONITIS; PRIORITY JOURNAL; RAT; SEPSIS; SKELETAL MUSCLE; SOLEUS MUSCLE; WISTAR RAT;

ANIMALS; MALATES; MALE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PERITONITIS; RATS; RATS, WISTAR; SEPSIS; SUCCINATES;

EID: 34548242254     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000281448.00095.4d     Document Type: Article

References (34)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Padkin A, Goldfrad C, Brady AR, et al: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-2338
3. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999; 27:1369-1377
4. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104
5. Hotchkiss RS, Rust RS, Dence CS, et al: Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol 1991; 261:R965-R972
6. Kreymann G, Grosser S, Buggisch P, et al: Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 1993; 21:1012-1019
7. Boekstegers P, Weidenhofer S, Kapsner T, et al: Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994; 22:640-650
8. Rosser DM, Stidwill RP, Jacobson D, et al: Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 1995; 79:1878-1882
9. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
10. Singer M, De Santis V, Vitale D, et al: Multiorgan failure is an adaptive, endocrinemediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548
11. Fink MP: Cytopathic hypoxia: Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit Care Clin 2002; 18:165-175
12. Crouser ED: Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 2004; 4:729-741
13. Singer M, Brealey D: Mitochondrial dysfunction in sepsis. Biochem Soc Symp 1999; 66:149-166
14. Brand MD: The efficiency and plasticity of mitochondrial energy transduction. Biochem Soc Trans 2005; 33:897-904
15. Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552:335-344
16. Brealey D, Brand M, Hargreaves I, et al: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223
17. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497
18. Svistunenko DA, Davies N, Brealey D, et al: Mitochondrial dysfunction in patients with severe sepsis: An EPR interrogation of individual respiratory chain components. Biochim Biophys Acta 2006; 1757:262-272
19. Trumbeckaite S, Opalka JR, Neuhof C, et al: Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur J Biochem 2001; 268:1422-1429
20. Callahan LA, Supinski GS: Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 2005; 172:861-868
21. Fredriksson K, Hammarqvist F, Strigard K, et al: Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis induced multiple organ failure. Am J Physiol Endocrinol Metab 2006; 291:E1044-E1050
22. Skladal D, Sperl W, Schranzhofer R, et al: Preservation of mitochondrial functions in human skeletal muscle during storage in high energy preservation solution (HEPS). In: What Is Controlling Life? Modern Trends in BioThermoKinetics 3. Gnaiger E, Gellerich FN, Wyss M (Eds). Innsbruck, Innsbruck University Press, 1994, pp 268-271
23. Ragan CI, Wilson MT, Darley-Usmar VM, et al: Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In: Mitochondria: A Practical Approach. Darley-Usmar VM, Rickwood D, Wilson MT (Eds). Oxford, IRL Press, 1987, pp 79-112
24. Welty-Wolf KE, Simonson SG, Huang YC, et al: Ultrastructural changes in skeletal muscle mitochondria in Gram-negative sepsis. Shock 1996; 5:378-384
25. Angeras U, Hall-Angeras M, Wagner KR, et al: Tissue metabolite levels in different types of skeletal muscle during sepsis. Metabolism 1991; 40:1147-1151
26. Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 2000; 28:N37-N52
27. Brown GC, Borutaite V: Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 2004; 1658:44-49
28. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437:1032-1037
29. Cairns CB, Ferroggiaro AA, Walther JM, et al: Postischemic administration of succinate reverses the impairment of oxidative phosphorylation after cardiac ischemia and reperfusion injury. Circulation 1997; 96(9 Suppl):II-260-II-265
30. Oguro H, Iijima K, Takahashi K, et al: Successful treatment with succinate in a patient with MELAS. Intern Med 2004; 43:427-431
31. Roef MJ, de Meer K, Reijngoud DJ, et al: Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency. Am J Clin Nutr 2002; 75:237-244
32. Doctor RB, Bacallao R, Mandel LJ: Method for recovering ATP content and mitochondrial function after chemical anoxia in renal cell cultures. Am J Physiol 1994; 266:C1803-C1811
33. Malaisse WJ, Nadi AB, Ladriere L, et al: Protective effects of succinic acid dimethyl ester infusion in experimental endotoxemia. Nutrition 1997; 13:330-341
34. Ferreira FL, Ladriere L, Vincent JL, et al: Prolongation of survival time by infusion of succinic acid dimethyl ester in a caecal ligation and perforation model of sepsis. Horm Metab Res 2000; 32:335-336